Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Jonasson, Jon Gunnlaugur
Ogmundsdottir, Helga M
MetadataShow full item record
CitationGenes Chromosomes Cancer 2004, 41(1):47-55
AbstractCytogenetic changes are common in breast cancer and have also been described in fibroadenomas and fibrocystic disease, but not in histologically normal breast tissue. Cytogenetic analysis was performed on nonmalignant breast tissue from benign breast lumps (n = 8), reduction mammoplasties (n = 31), and grossly nontumorous tissue from cancerous breasts (n = 84), using standard techniques and G-banding. All samples were reviewed histologically. Clonal chromosomal changes were found in three of eight benign breast tumors (38%). Of the reduction mammoplasties, 17 samples contained nonproliferative changes, and three of these (18%) showed a clonal deletion of 3p. No pathology was identified in the other 14 samples, of which one (7%) contained two clonal changes, apparently balanced translocations. Of nontumorous tissues from cancerous breasts, 15 (18%) showed clonal chromosomal abnormalities. Five of these samples were histologically normal. Two clones were identical to those found in the corresponding cancer. In 18 additional samples, single cells were detected with the same change as that seen in clones or single cells in the cancer. Only 4 of these 20 samples contained detectable cancer cells. Clonal abnormalities found in two or more samples included trisomies X, 7, and 20 and monosomies 19 and 18. Clonal changes were not significantly more frequent in proliferative than in nonproliferative lesions. The Icelandic BRCA2 founder mutation, 999del5, was detected in four samples, all histologically normal, two of which had clonal chromosomal abnormalities. In conclusion, clonal chromosomal changes are not infrequent in nonmalignant breast tissue and can be detected even in the absence of histological abnormalities.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer.
- Authors: Teixeira MR, Pandis N, Bardi G, Andersen JA, Heim S
- Issue date: 1996 Feb 15
- Cytogenetic polyclonality of breast carcinomas: association with clinico-pathological characteristics and outcome.
- Authors: Steinarsdottir M, Gudmundsson IH, Jonasson JG, Olafsdottir EJ, Eyfjörd JE, Ogmundsdottir HM
- Issue date: 2011 Nov
- Breast cancer cytogenetics: a review and proposal for clinical application.
- Authors: Cervantes M, Glassman AB
- Issue date: 1996 May-Jun
- Effect of hypoxia and TP53 mutation status and cytogenetics of normal and malignant mammary epithelium.
- Authors: Vidarsson H, Steinarsdóttir M, Jónasson JG, Júlíusdóttir H, Hauksdóttir H, Hilmarsdóttir H, Halldórsdóttir K, Ogmundsdóttir HM
- Issue date: 2006 Mar
- Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer.
- Authors: Adduci KM, Annis CE, DeVries S, Chew KL, Boutin J, Magrane G, Ljung BM, Waldman FM, Esserman LJ
- Issue date: 2007 Jun 25